Tenants
Biotechnology
Imaging
Engineering
- MR CoilTech
AURUM Biosciences Ltd develops novel pharmaceuticals for use in a number of different clinical indications of high unmet medical need. Aurum is currently completing preclinical development of ABL101, its lead stroke management product, and envisages initiating clinical studies of efficacy and safety in the near future. Follow-on programmes include products for heart disease, cancer, epilepsy, and dementia. Aurum’s lead project utilises an oxygen carrier and proprietary software for use with MRI in Acute Ischaemic Stroke. Aurum has funding in place to initiate recruitment for a Phase 2 clinical study in stroke patients.
The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics, to be known as iCAIRD, brings together a pan-Scotland collaboration of 15 partners from across academia, the NHS, and industry.
MR CoilTech is a unique company established to design, develop and manufacture specialist radio-frequency (RF) coil devices for high field MRI scanners, including 7T.
Spiritus is pioneering digital service records, analytics and actionable insights for healthcare and life sciences to protect patient safety, improve clinical outcomes and meet compliance obligations. We support health systems, medical device manufacturers and 3rd parties in establishing a ‘middle ground’ to share information in a permissioned, secure manner across an asset’s operating life.
West of Scotland Innovation Hub
The innovation hub is a part of the NHS - this draws in expertise across eHealth, R&D and clinical areas. The focus of our West of Scotland hub is to promote innovation across the 5 NHS boards that we cover; Ayrshire & Arran, Dumfries & Galloway, Forth Valley, Greater Glasgow & Clyde and Lanarkshire. We work with an number of companies, both SMEs and larger multinational companies. Our focus is to improve healthcare across the NHS whilst fitting in with regional and national agendas.